Physician profile
Danh Pham
NPI 1619312378
$1,083.88
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,051 · 2020: $32.61.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $202.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $166.47 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $116.63 | 2019 | |
| Foundation Medicine, INC. | $112.59 | 2019 | |
| Rigel Pharmaceuticals, INC. | $106.00 | 2019 | |
| Celgene Corporation | $63.24 | 2019 | |
| Eisai INC. | $60.84 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $44.12 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $37.78 | 2019 | |
| Janssen Biotech, INC. | $36.42 | 2019 | |
| Clovis Oncology, INC. | $30.26 | 2019 | |
| Lilly USA, LLC | $27.93 | 2019 | |
| Amag Pharmaceuticals, INC. | $19.44 | 2019 | |
| Novo Nordisk INC | $15.97 | 2019 | |
| Genzyme Corporation | $15.96 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $13.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.69 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danh Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.